Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Myelodysplastic Syndromes 21Lymphoma, Non-Hodgkin 17Leukemia 17Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Lymphoma 9Leukemia, Lymphocytic, Chronic, B-Cell 8Hodgkin Disease 8Hematologic Neoplasms 7Leukemia, Myeloid, Accelerated Phase 6Leukemia, Biphenotypic, Acute 6Congenital Abnormalities 6Blast Crisis 6Anemia, Refractory, with Excess of Blasts 6Multiple Myeloma 5Lymphoma, Large B-Cell, Diffuse 5Breast Neoplasms 5Neuroblastoma 4Lymphoma, Mantle-Cell 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myelomonocytic, Juvenile 4Graft vs Host Disease 4Burkitt Lymphoma 4Recurrence 3Neuroectodermal Tumors, Primitive, Peripheral 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3

Interventions

fludarabine 1Thiotepa 1Muromonab-CD3 1Melphalan 1Immunotherapy 1Drug Therapy 1Cyclophosphamide 1Antibodies 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Histiocytosis × Thiotepa × Clear all
NCT00145626 2017-06-19

HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies

St. Jude Children's Research Hospital

Phase 2 Completed
40 enrolled 18 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡